Lipopeptide-based melanoma cancer vaccin
β
FrΓ©dΓ©rique-Anne Le Gal; Armelle Prevost-Blondel; RenΓ©e Lengagne; Marc Bossus; Fr
π
Article
π
2001
π
John Wiley and Sons
π
French
β 143 KB
## Abstract Identification of tumor antigens and their optimal antigenic peptides raised hopes for the development of peptideβbased immunotherapeutic vaccine strategies for human melanoma, however. Synthetic peptides alone are not immunogenic enough, and adequate formulation is critical for elabora